MDWD
Mediwound LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$208.85M
P/E Ratio
—
EPS
$-2.10
Beta
0.15
52W High
$22.50
52W Low
$14.90
50-Day MA
$17.02
200-Day MA
$17.87
Dividend Yield
—
Profit Margin
-140.80%
Forward P/E
34.97
PEG Ratio
-0.07
About Mediwound Ltd
MediWound Ltd., a biopharmaceutical company, develops, manufactures and markets new and biotherapeutic solutions for tissue repair and regeneration. The company is headquartered in Yavne, Israel.
Fundamentals
| Revenue (TTM) | $16.96M |
| Gross Profit (TTM) | $3.25M |
| EBITDA | $-24.28M |
| Operating Margin | -417.80% |
| Return on Equity | -63.90% |
| Return on Assets | -19.80% |
| Revenue/Share (TTM) | $1.49 |
| Book Value | $3.40 |
| Price-to-Book | 4.79 |
| Price-to-Sales (TTM) | 12.31 |
| EV/Revenue | 9.66 |
| EV/EBITDA | -6.32 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -68.00% |
| Shares Outstanding | $12.85M |
| Float | $9.76M |
| % Insiders | 15.86% |
| % Institutions | 57.11% |
Historical Volatility
HV 10-Day
38.54%
HV 20-Day
36.46%
HV 30-Day
43.21%
HV 60-Day
38.69%
HV Rank
66.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($31.33 target)
1
Strong Buy5
BuyData last updated: 4/30/2026